Experts say that the relatively low hospitalisation and fatality rates in India suggest the coronavirus pandemic is approaching its next phase - largely manageable local outbreaks. ( read original story ...)
Vaccine exporter India says it has plenty of shots for its own people
The government assured Indians on Tuesday that there were plenty of COVID-19 vaccines for the country even though it has sent quantities overseas. ( read original story ...)
Exclusive: India woos Tesla with offer of cheaper production costs than China
India is ready to offer incentives to ensure Tesla Inc's cost of production would be less than in China if the carmaker commits to making its electric vehicles in the south Asian country, transport ... ( read original story ...)
China fears overseas market ‘bubble’; German exports to UK down 30% in January – business live
China’s CSI 300 stock market index dropped by over 1% today, with Guo Shuqing’s comments about bubbles abroad worrying traders. Other markets in the region also dipped: Castor Pang, head of research ... ( read original story ...)
China Seen Cutting Local Government Bond Quota to Curb Debt
China is set to reduce local government bond sales and rein in its budget deficit this year, scaling back the pandemic stimulus measures that fueled debt while helping the economy recover. ( read original story ...)
Purple Biotech Provides Corporate Update and Reports Second Half and Full Year 2020 Financial Results
Purple Biotech Ltd. (“Purple Biotech”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective, and durable therapies by overcoming tumor immune evasion and drug resistance, ... ( read original story ...)
Syrian victims of chemical attacks file case with French prosecutors
Lawyers representing survivors of a chemical weapons attack in 2013 in Syria have filed a criminal complaint against Syrian officials whom they blame for the deaths of hundreds of civilians in a rebel ... ( read original story ...)
Malaysia approves Sinovac, AstraZeneca COVID-19 vaccines for use
KUALA LUMPUR (Reuters) - Malaysia on Tuesday granted conditional approval for the use of vaccines made by UK firm AstraZeneca and China's Sinovac, just days after launching its nationwide COVID-19 ... ( read original story ...)
Malaysia’s Sukuk Prihatin wins IFN’s global deal of the year award
Malaysia's RM666-million fully digital Sukuk Prihatin launched last year has won the prestigious 2020 IFN Overall Deal of the Year award, edging out three other exce ... ( read original story ...)
MITI: Malaysia records RM164b of total approved investments in 2020 amid global pandemic
Amid challenging global economic environment due to the Covid-19 pandemic, Malaysia recorded a total of RM164 billion in approved investments through 4,599 projects in the manufacturing, services and ... ( read original story ...)